Search Results for citation:"86 FR 8212"

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on March 24, 2021, to discuss grant applications for the advancement of cell replacement therapies for Type 1 Diabetes. This meeting is not open to the public to protect confidential information, including trade secrets and personal privacy. The meeting will be conducted via teleconference from the National Institutes of Health in Bethesda, Maryland. Dr. Ann A. Jerkins is the contact person for this meeting.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting of the Allergy, Immunology, and Transplantation Research Committee (AITC) on February 25-26, 2021. This meeting is closed to the public as it will involve discussions of confidential information concerning grant applications, which may include trade secrets and personal details of the applicants. The agenda of the meeting is to review and evaluate these grant applications. The virtual meeting will be held at the National Institutes of Health in Rockville, Maryland.

The National Institute of Mental Health has announced a closed meeting of the Special Emphasis Panel on February 26, 2021, to review grant applications related to the BRAIN Initiative. This meeting will be held via telephone conference at the National Institutes of Health Neuroscience Center in Rockville, MD. The meeting will be closed to the public because it involves discussions of confidential grant applications and personal information, which, if disclosed, could invade personal privacy or reveal trade secrets. For more details, Rebecca Steiner Garcia, Ph.D., is the Scientific Review Officer coordinating these activities.

The National Center for Complementary and Integrative Health (NCCIH) announced a closed meeting to review grant applications related to mind and body interventions. This meeting will take place virtually on March 2-3, 2021, from 10:00 a.m. to 5:00 p.m. Confidential information may be discussed, so it will not be open to the public. Pamela Jeter, Ph.D., is the Scientific Review Officer overseeing the event.